The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors
Open accessAbstract
Purpose: To evaluate the relationship between race/ethnicity and breast cancer–specific survival according to subtype and explore mediating factors. Patients and Methods: Participants were women presenting with stage I to III breast cancer between January 2000 and December 2007 at National Comprehensive Cancer Network centers with survival follow-up through December 2009. Cox proportional hazards regression was used to compare breast cancer–specific survival among Asians (n = 533), Hispanics (n = 1,122), and blacks (n = 1,345) with that among whites (n = 14,268), overall and stratified by subtype (luminal A like, luminal B like, human epidermal growth factor receptor 2 type, and triple negative). Model estimates were used to derive mediation proportion and 95% CI for selected risk factors. Results: In multivariable adjusted models, overall, blacks had 21% higher risk of breast cancer–specific death (hazard ratio [HR], 1.21; 95% CI, 1.00 to 1.45). For estrogen receptor–positive tumors, black and white survival differences were greatest within 2 years of diagnosis (years 0 to 2: HR, 2.65; 95% CI, 1.34 to 5.24; year 2 to end of follow-up: HR, 1.50; 95% CI, 1.12 to 2.00). Blacks were 76% and 56% more likely to die as a result of luminal A–like and luminal B–like tumors, respectively. No disparities were observed for triple-negative or human epidermal growth factor receptor 2–type tumors. Asians and Hispanics were less likely to die as a result of breast cancer compared with whites (Asians: HR, 0.56; 95% CI, 0.37 to 0.85; Hispanics: HR, 0.74; 95% CI, 0.58 to 0.95). For blacks, tumor characteristics and stage at diagnosis were significant disparity mediators. Body mass index was an important mediator for blacks and Asians. Conclusion: Racial disparities in breast cancer survival vary by tumor subtype. Interventions are needed to reduce disparities, particularly in the first 2 years after diagnosis among black women with estrogen receptor–positive tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
American Joint Committee on Cancer (2002) · Springer eBooks · doi:10.1007/978-1-4757-3656-4 · Cited by 6,379
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Trastuzumab-Induced Hepatotoxicity: A Case Report
Vucicevic, D., Carey, E. J., & Karlin, N. J. (2013) · Breast Care · doi:10.1159/000346844 · Cited by 4,415
Goldhirsch, A., Wood, W. C., Coates, A. S., Gelber, R. D., Thürlimann, B., & Senn, H.-J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr304 · Cited by 3,836
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
Carey, L. A., Perou, C. M., Livasy, C. A., Dressler, L. G., Cowan, D., Conway, K., Karaca, G., Troester, M. A., Tse, C. K., Edmiston, S., et al. (2006) · JAMA · doi:10.1001/jama.295.21.2492 · Cited by 3,819
Cheang, M. C. U., Voduc, D., Bajdik, C., Leung, S., McKinney, S., Chia, S. K., Perou, C. M., & Nielsen, T. O. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1658 · Cited by 1,195
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
Singletary, S. E., Allred, C., Ashley, P., Bassett, L. W., Berry, D., Bland, K. I., Borgen, P. I., Clark, G., Edge, S. B., Hayes, D. F., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.026 · Cited by 1,173
Self-citationCan Comorbidity Be Measured By Questionnaire Rather than Medical Record Review?
KATZ, J. N., CHANG, L. C., SANGHA, O., FOSSEL, A. H., & BATES, D. W. (1996) · Medical Care · doi:10.1097/00005650-199601000-00006 · Cited by 1,035
Racial and Ethnic Disparities in the Receipt of Cancer Treatment
Shavers, V. L. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.5.334 · Cited by 950
Aromatase Inhibitors in Breast Cancer
Smith, I. E., & Dowsett, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023246 · Cited by 905
Triple-negative breast cancer: therapeutic options
Cleator, S., Heller, W., & Coombes, R. C. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70074-8 · Cited by 882
Hershman, D. L., Shao, T., Kushi, L. H., Buono, D., Tsai, W. Y., Fehrenbacher, L., Kwan, M., Gomez, S. L., & Neugut, A. I. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1132-4 · Cited by 870
Loi, S., Haibe-Kains, B., Desmedt, C., Lallemand, F., Tutt, A. M., Gillet, C., Ellis, P., Harris, A., Bergh, J., Foekens, J. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1522 · Cited by 837
Hershman, D. L., Kushi, L. H., Shao, T., Buono, D., Kershenbaum, A., Tsai, W.-Y., Fehrenbacher, L., Lin Gomez, S., Miles, S., & Neugut, A. I. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9655 · Cited by 828
Lin, N. U., Vanderplas, A., Hughes, M. E., Theriault, R. L., Edge, S. B., Wong, Y., Blayney, D. W., Niland, J. C., Winer, E. P., & Weeks, J. C. (2012) · Cancer · doi:10.1002/cncr.27581 · Cited by 695
Self-citationNonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
Partridge, A. H., Wang, P. S., Winer, E. P., & Avorn, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.071 · Cited by 676
Self-citationWeight, Weight Gain, and Survival After Breast Cancer Diagnosis
Kroenke, C. H., Chen, W. Y., Rosner, B., & Holmes, M. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.079 · Cited by 670
Differences in Breast Cancer Stage, Treatment, and Survival by Race and Ethnicity
Li, C. I., Malone, K. E., & Daling, J. R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.1.49 · Cited by 662
Race, Socioeconomic Status, and Breast Cancer Treatment and Survival
Bradley, C. J. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.7.490 · Cited by 658
Patient adherence and persistence with oral anticancer treatment
Ruddy, K., Mayer, E., & Partridge, A. (2009) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20004 · Cited by 569
Self-citationPatient navigation: An update on the state of the science
Paskett, E. D., Harrop, J. P., & Wells, K. J. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20111 · Cited by 458
Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolina Breast Cancer Study
O'Brien, K. M., Cole, S. R., Tse, C.-K., Perou, C. M., Carey, L. A., Foulkes, W. D., Dressler, L. G., Geradts, J., & Millikan, R. C. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1533 · Cited by 429
Classification and prognosis of invasive breast cancer: from morphology to molecular taxonomy
Schnitt, S. J. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.33 · Cited by 419
Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA
Lund, M. J., Trivers, K. F., Porter, P. L., Coates, R. J., Leyland-Jones, B., Brawley, O. W., Flagg, E. W., O’Regan, R. M., Gabram, S. G. A., & Eley, J. W. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9926-3 · Cited by 390
Platet, N., Cathiard, A. M., Gleizes, M., & Garcia, M. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.02.001 · Cited by 367
Newman, L. A., Griffith, K. A., Jatoi, I., Simon, M. S., Crowe, J. P., & Colditz, G. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.3472 · Cited by 362
Neugut, A. I., Subar, M., Wilde, E. T., Stratton, S., Brouse, C. H., Hillyer, G. C., Grann, V. R., & Hershman, D. L. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.3179 · Cited by 354
Parise, C. A., Bauer, K. R., Brown, M. M., & Caggiano, V. (2009) · The Breast Journal · doi:10.1111/j.1524-4741.2009.00822.x · Cited by 331
Impact of Patient Navigation on Timely Cancer Care: The Patient Navigation Research Program
Freund, K. M., Battaglia, T. A., Calhoun, E., Darnell, J. S., Dudley, D. J., Fiscella, K., Hare, M. L., LaVerda, N., Lee, J.-H., Levine, P., et al. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju115 · Cited by 303
Delays in Breast Cancer Diagnosis and Treatment by Racial/Ethnic Group
Gorin, S. S. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.20.2244 · Cited by 294
Engstrøm, M. J., Opdahl, S., Hagen, A. I., Romundstad, P. R., Akslen, L. A., Haugen, O. A., Vatten, L. J., & Bofin, A. M. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2647-2 · Cited by 238
Age-Specific Incidence of Breast Cancer Subtypes: Understanding the Black–White Crossover
Clarke, C. A., Keegan, T. H. M., Yang, J., Press, D. J., Kurian, A. W., Patel, A. H., & Lacey, J. V. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs264 · Cited by 228
Christian, C. K., Niland, J., Edge, S. B., Ottesen, R. A., Hughes, M. E., Theriault, R., Wilson, J., Hergrueter, C. A., & Weeks, J. C. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000197738.63512.23 · Cited by 202
Self-citationWeidner, N., Moore II, D. H., & Vartanian, R. (1994) · Human Pathology · doi:10.1016/0046-8177(94)90140-6 · Cited by 190
Wu, X.-C., Lund, M. J., Kimmick, G. G., Richardson, L. C., Sabatino, S. A., Chen, V. W., Fleming, S. T., Morris, C. R., Huang, B., Trentham-Dietz, A., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.8399 · Cited by 190
Trihia, H., Murray, S., Price, K., Gelber, R. D., Golouh, R., Goldhirsch, A., Coates, A. S., Collins, J., Castiglione‐Gertsch, M., & Gusterson, B. A. (2003) · Cancer · doi:10.1002/cncr.11188 · Cited by 189
Obesity at Diagnosis of Breast Carcinoma Influences Duration of Disease-free Survival
Senie, R. T., Rosen, P. P., Rhodes, P., Lesser, M. L., & Kinne, D. W. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-26 · Cited by 180
Hershman, D. L., Wang, X., McBride, R., Jacobson, J. S., Grann, V. R., & Neugut, A. I. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.03.048 · Cited by 175
Newman, L. A., Mason, J., Cote, D., Vin, Y., Carolin, K., Bouwman, D., & Colditz, G. A. (2002) · Cancer · doi:10.1002/cncr.10575 · Cited by 175
NG'ANDU, N. H. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970330)16:6<611::aid-sim437>3.0.co;2-t · Cited by 173
Fedewa, S. A., Ward, E. M., Stewart, A. K., & Edge, S. B. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.2427 · Cited by 164
Self-citationHunt, B. R., Whitman, S., & Hurlbert, M. S. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2013.09.009 · Cited by 164
Gomez, S. L., Clarke, C. A., Shema, S. J., Chang, E. T., Keegan, T. H. M., & Glaser, S. L. (2010) · American Journal of Public Health · doi:10.2105/ajph.2009.176651 · Cited by 153
Social and Racial Differences in Selection of Breast Cancer Adjuvant Chemotherapy Regimens
Griggs, J. J., Culakova, E., Sorbero, M. E. S., Poniewierski, M. S., Wolff, D. A., Crawford, J., Dale, D. C., & Lyman, G. H. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.2749 · Cited by 149
Vandergrift, J. L., Niland, J. C., Theriault, R. L., Edge, S. B., Wong, Y., Loftus, L., Breslin, T. M., Hudis, C. A., Javid, S. H., Rugo, H. S., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs506 · Cited by 131
Self-citationVariation in breast cancer subtypes with age and race/ethnicity
Parise, C. A., Bauer, K. R., & Caggiano, V. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.09.002 · Cited by 112
Race and Hormone Receptor–Positive Breast Cancer Outcomes in a Randomized Chemotherapy Trial
Sparano, J. A., Wang, Μ., Zhao, F., Stearns, V., Martino, S., Ligibel, J. A., Perez, E. A., Saphner, T., Wolff, A. C., Sledge, G. W., et al. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr543 · Cited by 108
Time to diagnosis and breast cancer stage by race/ethnicity
Warner, E. T., Tamimi, R. M., Hughes, M. E., Ottesen, R. A., Wong, Y., Edge, S. B., Theriault, R. L., Blayney, D. W., Niland, J. C., Winer, E. P., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2304-1 · Cited by 102
Self-citationKo, N. Y., Darnell, J. S., Calhoun, E. A., Freund, K. M., Wells, K., Shapiro, C. L., Dudley, D. J., Patierno, S. R., Fiscella, K. A., Raich, P. C., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.6037 · Cited by 99
Keegan, T. H. M., Quach, T., Shema, S. J., Glaser, S. L., & Gomez, S. L. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-603 · Cited by 99
Friese, C. R., Pini, T. M., Li, Y., Abrahamse, P. H., Graff, J. J., Hamilton, A. S., Jagsi, R., Janz, N. K., Hawley, S. T., Katz, S. J., et al. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2499-9 · Cited by 95
Livaudais, J. C., Hershman, D. L., Habel, L., Kushi, L., Gomez, S. L., Li, C. I., Neugut, A. I., Fehrenbacher, L., Thompson, B., & Coronado, G. D. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1762-1 · Cited by 93
Determinants of Breast Cancer Treatment Delay Differ for African American and White Women
McGee, S., Durham, D. D., Tse, C., & Millikan, R. C. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1432 · Cited by 92
Breast cancer characteristics and outcomes among Hispanic Black and Hispanic White women
Banegas, M. P., & Li, C. I. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2142-1 · Cited by 82
Nurgalieva, Z. Z., Franzini, L., Morgan, R. O., Vernon, S. W., Liu, C. C., & Du, X. L. (2013) · Medical Oncology · doi:10.1007/s12032-012-0419-1 · Cited by 68
Magai, C., Consedine, N. S., Adjei, B. A., Hershman, D. L., & Neugut, A. I. (2006) · Health Education & Behavior · doi:10.1177/1090198107303281 · Cited by 46
Livaudais, J. C., LaCroix, A. Z., Chlebowski, R. T., Li, C. I., Habel, L. A., Simon, M. S., Thompson, B., Erwin, D. O., Hubbell, F. A., & Coronado, G. D. (2012) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-12-1225 · Cited by 29
Cited by
Siegel, R. L., Miller, K. D., & Jemal, A. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21332 · Cited by 16,003
Breast cancer statistics, 2019
DeSantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Goding Sauer, A., Jemal, A., & Siegel, R. L. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21583 · Cited by 3,114
Breast Cancer Statistics, 2022
Giaquinto, A. N., Sung, H., Miller, K. D., Kramer, J. L., Newman, L. A., Minihan, A., Jemal, A., & Siegel, R. L. (2022) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21754 · Cited by 2,286
Breast cancer statistics, 2017, racial disparity in mortality by state
DeSantis, C. E., Ma, J., Goding Sauer, A., Newman, L. A., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21412 · Cited by 1,879
Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
Jemal, A., Ward, E. M., Johnson, C. J., Cronin, K. A., Ma, J., Ryerson, A. B., Mariotto, A., Lake, A. J., Wilson, R., Sherman, R. L., et al. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx030 · Cited by 1,556
Metadata
- Authors
- Warner, E. T., Tamimi, R. M., Hughes, M. E., Ottesen, R. A., Wong, Y.-N., Edge, S. B., Theriault, R. L., Blayney, D. W., Niland, J. C., Winer, E. P., Weeks, J. C., & Partridge, A. H.
- Venue
- Journal of Clinical Oncology
- Published
- 2015-07-10
- Volume
- 33
- Issue
- 20
- Pages
- 2254-2261
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2166149308
- Cited by
- 280
- References
- 59
- FWCI
- 9.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.